Ali Adili
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Co-authors
- Navid Shomali (12 shared papers)Lakshmi Thangavelu (7 shared papers)Rebar N. Mohammed (4 shared papers)Wanich Suksatan (2 shared papers)Supat Chupradit (2 shared papers)Ali Noroozi‐Aghideh (1 shared paper)Adel Naimi (1 shared paper)Alexei Valerievich Yumashev (1 shared paper)
In The Last Decade
Ali Adili
28 papers receiving 606 citations
Ali Adili's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 237
- Immunology 160
- Cancer Research 91
- Molecular Biology 196
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Ali Adili
This map shows the geographic impact of Ali Adili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Adili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Adili more than expected).
Fields of papers citing papers by Ali Adili
This network shows the impact of papers produced by Ali Adili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Adili. The network helps show where Ali Adili may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Adili, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons Hit paper breakdown → | 2022 | 339 |
| 2 | 2022 | 34 | |
| 3 | 2016 | 31 | |
| 4 | 2021 | 25 | |
| 5 | 2022 | 20 | |
| 6 | 2022 | 20 | |
| 7 | 2023 | 18 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 12 | |
| 10 | 2019 | 12 | |
| 11 | 2015 | 12 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2023 | 7 | |
| 17 | 2021 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 4 |
About Ali Adili
Ali Adili is a scholar working on Molecular Biology, Cancer Research, Oncology, Infectious Diseases and Clinical Psychology, having authored 29 papers that have together received 610 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), COVID-19 Clinical Research Studies (5 papers), CAR-T cell therapy research (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 and Mental Health (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (237 citations), Immunology (160 citations), Cancer Research (91 citations), Molecular Biology (196 citations) and Pulmonary and Respiratory Medicine (74 citations). Ali Adili has collaborated with scholars based in Iran, Iraq and Russia. Frequent co-authors include Navid Shomali, Lakshmi Thangavelu, Rebar N. Mohammed, Wanich Suksatan, Supat Chupradit, Ali Noroozi‐Aghideh, Adel Naimi, Alexei Valerievich Yumashev, Ehsan Razeghian and Mohammed Nader Shalaby. Their work appears in journals such as Cell Communication and Signaling, Journal of Cellular and Molecular Medicine, Cancer Cell International, IUBMB Life and Cellular & Molecular Biology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.